A meta-analysis by Sun et al. [103] showed that increased CTR1 expression was significantly associated with a favorable overall and disease-free survival, suggesting that CTR1 could be a potential prognostic factor for the survival of cancer patients who underwent chemotherapy. The gene discussed is SLC31A1; the disease is cancer.